Literature DB >> 27906788

DS02R1: Improvements to Atomic Bomb Survivors' Input Data and Implementation of Dosimetry System 2002 (DS02) and Resulting Changes in Estimated Doses.

H M Cullings1, E J Grant, S D Egbert, T Watanabe, T Oda, F Nakamura, T Yamashita, H Fuchi, S Funamoto, K Marumo, R Sakata, Y Kodama, K Ozasa, K Kodama.   

Abstract

Individual dose estimates calculated by Dosimetry System 2002 (DS02) for the Life Span Study (LSS) of atomic bomb survivors are based on input data that specify location and shielding at the time of the bombing (ATB). A multi-year effort to improve information on survivors' locations ATB has recently been completed, along with comprehensive improvements in their terrain shielding input data and several improvements to computational algorithms used in combination with DS02 at RERF. Improvements began with a thorough review and prioritization of original questionnaire data on location and shielding that were taken from survivors or their proxies in the period 1949-1963. Related source documents varied in level of detail, from relatively simple lists to carefully-constructed technical drawings of structural and other shielding and surrounding neighborhoods. Systematic errors were reduced in this work by restoring the original precision of map coordinates that had been truncated due to limitations in early data processing equipment and by correcting distortions in the old (WWII-era) maps originally used to specify survivors' positions, among other improvements. Distortion errors were corrected by aligning the old maps and neighborhood drawings to orthophotographic mosaics of the cities that were newly constructed from pre-bombing aerial photographs. Random errors that were reduced included simple transcription errors and mistakes in identifying survivors' locations on the old maps. Terrain shielding input data that had been originally estimated for limited groups of survivors using older methods and data sources were completely re-estimated for all survivors using new digital terrain elevation data. Improvements to algorithms included a fix to an error in the DS02 code for coupling house and terrain shielding, a correction for elevation at the survivor's location in calculating angles to the horizon used for terrain shielding input, an improved method for truncating high dose estimates to 4 Gy to reduce the effect of dose error, and improved methods for calculating averaged shielding transmission factors that are used to calculate doses for survivors without detailed shielding input data. Input data changes are summarized and described here in some detail, along with the resulting changes in dose estimates and a simple description of changes in risk estimates for solid cancer mortality. This and future RERF publications will refer to the new dose estimates described herein as "DS02R1 doses."

Entities:  

Mesh:

Year:  2017        PMID: 27906788     DOI: 10.1097/HP.0000000000000598

Source DB:  PubMed          Journal:  Health Phys        ISSN: 0017-9078            Impact factor:   1.316


  21 in total

1.  Radiation risk of central nervous system tumors in the Life Span Study of atomic bomb survivors, 1958-2009.

Authors:  Alina V Brenner; Hiromi Sugiyama; Dale L Preston; Ritsu Sakata; Benjamin French; Atsuko Sadakane; Elizabeth K Cahoon; Mai Utada; Kiyohiko Mabuchi; Kotaro Ozasa
Journal:  Eur J Epidemiol       Date:  2020-01-25       Impact factor: 8.082

2.  Misclassification of primary liver cancer in the Life Span Study of atomic bomb survivors.

Authors:  Benjamin French; Atsuko Sadakane; John Cologne; Kiyohiko Mabuchi; Kotaro Ozasa; Dale L Preston
Journal:  Int J Cancer       Date:  2020-02-15       Impact factor: 7.396

3.  Medical Radiation Exposure among Atomic Bomb Survivors: Understanding its Impact on Risk Estimates of Atomic Bomb Radiation.

Authors:  Atsuko Sadakane; Reid D Landes; Ritsu Sakata; Jun Nagano; Roy E Shore; Kotaro Ozasa
Journal:  Radiat Res       Date:  2019-03-29       Impact factor: 2.841

Review 4.  Issues in Interpreting Epidemiologic Studies of Populations Exposed to Low-Dose, High-Energy Photon Radiation.

Authors:  Ethel S Gilbert; Mark P Little; Dale L Preston; Daniel O Stram
Journal:  J Natl Cancer Inst Monogr       Date:  2020-07-01

5.  Selection of reference groups in the Life Span Study of atomic bomb survivors.

Authors:  Benjamin French; John Cologne; Ritsu Sakata; Mai Utada; Dale L Preston
Journal:  Eur J Epidemiol       Date:  2017-12-04       Impact factor: 8.082

6.  Lifetime Mortality Risk from Cancer and Circulatory Disease Predicted from the Japanese Atomic Bomb Survivor Life Span Study Data Taking Account of Dose Measurement Error.

Authors:  Mark P Little; David Pawel; Munechika Misumi; Nobuyuki Hamada; Harry M Cullings; Richard Wakeford; Kotaro Ozasa
Journal:  Radiat Res       Date:  2020-09-16       Impact factor: 2.841

7.  Effect of Heterogeneity in Background Incidence on Inference about the Solid-Cancer Radiation Dose Response in Atomic Bomb Survivors.

Authors:  John Cologne; Jaeyoung Kim; Hiromi Sugiyama; Benjamin French; Harry M Cullings; Dale L Preston; Kiyohiko Mabuchi; Kotaro Ozasa
Journal:  Radiat Res       Date:  2019-07-29       Impact factor: 2.841

8.  Population Density in Hiroshima and Nagasaki Before the Bombings in 1945: Its Measurement and Impact on Radiation Risk Estimates in the Life Span Study of Atomic Bomb Survivors.

Authors:  Benjamin French; Sachiyo Funamoto; Hiromi Sugiyama; Ritsu Sakata; John Cologne; Harry M Cullings; Kiyohiko Mabuchi; Dale L Preston
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

Review 9.  Individual response of humans to ionising radiation: governing factors and importance for radiological protection.

Authors:  K E Applegate; W Rühm; A Wojcik; M Bourguignon; A Brenner; K Hamasaki; T Imai; M Imaizumi; T Imaoka; S Kakinuma; T Kamada; N Nishimura; N Okonogi; K Ozasa; C E Rübe; A Sadakane; R Sakata; Y Shimada; K Yoshida; S Bouffler
Journal:  Radiat Environ Biophys       Date:  2020-03-07       Impact factor: 1.925

10.  Probability Distribution of Dose and Dose-Rate Effectiveness Factor for use in Estimating Risks of Solid Cancers From Exposure to Low-Let Radiation.

Authors:  David C Kocher; A Iulian Apostoaei; F Owen Hoffman; John R Trabalka
Journal:  Health Phys       Date:  2018-06       Impact factor: 1.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.